Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Chemotherapy|October 15, 2011
Clinical and electrocardiography changes in patients treated with capecitabineDogan Koca, Tarik Salman, Ilkay Tugba Unek, et al.
Cancers|December 23, 2023
Beta-Hydroxybutyrate Augments Oxaliplatin-Induced Cytotoxicity by Altering Energy Metabolism in Colorectal Cancer OrganoidsTolga Sever, Ender Berat Ellidokuz, Yasemin Basbinar, et al.
Clinical Medicine & Research|July 28, 2010
The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese peopleIlkay Tugba Unek, Firat Bayraktar, Dilek Solmaz, et al.
Journal of Cancer Research and Therapeutics|April 14, 2016
The association of clinicopathological features and survival in colorectal cancer patients with kras mutation statusTulay Akman, Ilhan Oztop, Yasemin Baskin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 22, 2014
Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in TurkeySuna Cokmert, Hulya Ellidokuz, Lutfiye Demir, et al.
Journal of Gastrointestinal Oncology|August 2, 2014
KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomasYasemin Baskin, Yusuf Kagan Dagdeviren, Gizem Calibasi, et al.
Metabolism: Clinical and Experimental|December 17, 2009
Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndromeIlkay Tugba Unek, Firat Bayraktar, Dilek Solmaz, et al.
Medical Oncology (Northwood, London, England)|December 16, 2014
The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapyTulay Akman, Ilhan Oztop, Yasemin Baskin, et al.
Medicine|October 28, 2024
The prognostic role of survivin expression in breast cancer: A systematic review and meta-analysisBetul Bolat Kucukzeybek, Yuksel Kucukzeybek, Yasemin Basbinar, et al.
International Journal of Clinical Practice|February 23, 2021
Prognostic value of intraductal carcinoma for adjuvant radiotherapy candidates after radical prostatectomySedat Karakoc, Serdar Celik, Nilhan Kaya, et al.
Pageof 9